Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomised pilot study (DARINA)

INTRODUCTION: Two novel agents, dabigatran and rivaroxaban, recently gained market authorisation for prevention of venous thromboembolism (VTE) after hip and knee arthroplasty. However, safety data of the new oral anticoagulants with a long-term use of 42 days are not available for total knee arthro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: van Veen, Lucia, van Raay, Jos JAM, Gerritsma-Bleeker, Carina L E, Veeger, Nic JGM, van Hulst, Marinus
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2013
Assuntos:
Medical Management
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563127/
https://ncbi.nlm.nih.gov/pubmed/23355673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2012-002218
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares